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Objectives: Obesity prevalence is increasing worldwide. In South Africa, older and urbanised African women have significantly 
higher rates of obesity. Limited information is available on the relationship between anthropometric parameters, adipokines 
and metabolic health status of African women. This study investigated the relationship between obesity, adipokines and the 
components of metabolic syndrome in urban African women.
Methods: This study included 135 urban African women that were 26–63 years of age, identified with metabolic syndrome in 
the urban leg of the Assuring Health for All in the Free State (AHA-FS) study. To establish anthropometric status, the following 
measures were taken: body weight, height and waist circumference. Blood was drawn to determine leptin, adiponectin levels 
and metabolic status.
Results: Adiponectin levels in obese women were significantly decreased compared to normal weight women. Leptin levels 
and leptin:adiponectin ratios (L:A) were increased in the obese group compared to the overweight and normal weight groups. 
Leptin and L:A showed strong positive correlations with body mass index and waist circumference. Adiponectin levels decreased 
as the number of components of metabolic syndrome increased. The L:A ratio was significantly lower in women with elevated 
triglycerides and significantly higher in women with elevated blood glucose levels. Adiponectin levels were significantly lower 
in women with elevated blood glucose.
Conclusion: This study confirms the inverse relationship between adiponectin and leptin with increased body adiposity. Results 
indicate that waist circumference, fasting blood glucose and triglyceride levels are the metabolic syndrome components most 
closely associated with altered adiponectin and leptin levels and L:A in urban African women with metabolic syndrome.
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Introduction
Obesity is a global epidemic. In 2008, 1.4 billion adults were 
overweight. This number had escalated in 2014 to an alarming 
1.9 billion adults worldwide, including over 600 million obese 
men (11%) and women (15%).1 The high prevalence of 
overweight and obesity is observed in developing countries as 
well as countries undergoing epidemiological transition, such as 
South Africa.2,3 Various studies have reported that the overall 
prevalence of overweight and obesity is the highest among 
South African women. A comparison of the 2013 data from the 
South African National Health and Nutrition Examination Survey 
(SANHANES-1)4 with 2007 data released by the South African 
Department of Health5 revealed that obesity increased 
dramatically from 27% to 39.2% amongst females. Urban women 
had a significantly higher body mass index (BMI) than rural 
women. This disturbing increase in obesity is of great concern 
due to the association of obesity with type II diabetes, 
dyslipidaemia and cardiovascular disease.
Metabolic syndrome refers to the cluster of risk factors that 
increase the risk of developing type II diabetes mellitus and 
cardiovascular diseases. These components include central 
obesity (increased waist circumference), elevated triglycerides, 
reduced high density lipoprotein cholesterol (HDL-C) levels, 
elevated blood pressure or treatment of previously diagnosed 
hypertension, and elevated fasting glucose.6
It is widely accepted that a number of peptide hormones are 
released from adipocytes. The adipocyte-derived biologically 
active substances (adipokines), leptin and adiponectin, are 
implicated in the pathogenesis of metabolic syndrome. These 
proteins secreted by adipose tissue are dysregulated when the 
adipocyte mass is markedly altered.7 With increasing adiposity, 
adipokines with pro-inflammatory properties, for example 
leptin, are overproduced, while anti-inflammatory adipokines, 
for example adiponectin, are decreased.8 Various South African 
studies have demonstrated ethnic differences in leptin levels.9−11 
Normal and overweight African women had significantly higher 
serum leptin levels than their Caucasian counterparts, when 
matched for age and obesity.9
Various studies have also focused on the critical role of 
adiponectin and leptin in the development of metabolic 
syndrome.12,13 Wolfson et al.14 observed a strong positive 
association between adiponectin levels and HDL-C, but a 
negative association with triglycerides and glucose. They could 
not demonstrate an association between adiponectin and BMI. 
Schutte et al.11 reported significant inverse correlations in African 
women between adiponectin and age, BMI and fasting blood 
glucose, and positive correlations with HDL-C. Martins et al.15 
found that BMI as an index of overall adiposity was significantly 
associated with serum leptin and reported a strong correlation 
between leptin and insulin resistance. The leptin:adiponectin 
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ratio (L:A ratio) has also been indicated as a potentially clinically 
useful marker for metabolic syndrome.16,17 A study conducted in 
Japanese women investigated the association between L:A and 
components of metabolic syndrome. The results indicated a 
significant and gradual increase in L:A corresponding to the 
increase in the number of components of metabolic syndrome. A 
positive association between HDL-C, age and L:A ratio, but an 
inverse association between BMI, triglycerides and L:A ratio, was 
found.17
Despite increased understanding of the relationship between 
anthropometric, metabolic and inflammatory parameters, 
limited information is available on these parameters and the 
metabolic health status of urban African women. The increasing 
prevalence of metabolic syndrome in developing countries such 
as South Africa requires strategic health policies and intervention 
programmes. The primary goal of this study was to investigate 
the relationship between anthropometric and metabolic 
parameters, leptin and adiponectin in urban African women with 
metabolic syndrome. Consequently, the following objectives 
were pursued in this study population: (i) determine fasting 
adiponectin and leptin levels; (ii) investigate the association 
between BMI status and leptin and adiponectin levels; (iii) 
investigate the relationship between leptin and adiponectin 
levels and the components of metabolic syndrome; (iv) 
determine which components of metabolic syndrome are more 
closely related to altered adiponectin and leptin levels; and (v) 
determine whether ageing is associated with the an increasing 
number of components of metabolic syndrome.
Methods
Materials and setting
This study formed part of the baseline phase of the Assuring 
Health for All in the Free State (AHA-FS) epidemiological study. 
The urban leg of the study commenced in 2009 in Mangaung in 
the Free State. The number of plots in the Mangaung University 
Community Partnership Programme (MUCPP) service area was 
counted on a municipal map. An estimate was made of additional 
squatter households in open areas. A stratified proportional 
cluster sample was selected, stratified by area and formal plot/
squatter households in open areas. Using randomly selected X 
and Y coordinates, 100 starting points were selected. From each 
starting point five adjacent households were approached.
Study population and sample
A total of 387 households were included in the urban leg of this 
study. The total study sample consisted of 565 participants 
(adults and children). However, this article will focus only on 
anthropometric and metabolic parameters as well as adipokine 
levels of African female participants (26–63 years) identified with 
metabolic syndrome.
Procedures
Adult participants were interviewed to complete household 
sociodemographic and individual health questionnaires. The 
questionnaires also included information regarding risk factors 
for metabolic syndrome, for example a history of hypertension 
and diabetes.
To establish anthropometric status, body weight, height and 
waist circumference were measured. Anthropometric evaluation 
was done after an overnight fast, in an examination gown and 
without shoes. Weight was determined using a Seca® (Germany) 
digital electronic foot scale. Anthropometric indices calculated 
included BMI [weight in kilograms divided by height in meters 
squared (kg/m2)]. Underweight was defined as BMI < 18.5 kg/m2, 
normal weight as BMI 18.5–24.9 kg/m2, overweight (pre-obese) 
as BMI 25–29.9 kg/m2 and obese as BMI ≥ 30 kg/m2.18 The cut-off 
point for central obesity was a waist circumference of ≥ 80 cm for 
women.6,19 The World Health Organisation’s STEPwise Approach 
to Surveillance (WHO STEPS) protocol for measuring waist 
circumference was followed.20
Participants underwent medical examinations and blood 
sampling to determine leptin, adiponectin levels and metabolic 
profiles. Blood pressure was measured in the supine position 
with a DS-175, auto-inflate digital electronic blood pressure 
monitor (Nissei, Japan). Urgent medical conditions were referred 
on the day of medical examination. All data forms and blood 
sample results were reviewed for referral. Communities were 
visited by medical practitioners again and participants could 
obtain results of biochemical tests and referral letters. If 
participants did not attend the individual feedback appointments, 
referral letters were delivered to participants by community 
workers. Patients were referred to local clinics, local health care 
providers and health care centers.
All serum and plasma samples were prepared in the laboratory 
according to standard methods and stored at -80 °C until analyses 
were performed. Leptin levels were determined using a 
quantitative sandwich enzyme immunoassay technique 
(Quantikine®, Human Leptin Immunoassay, R&D Systems, Inc., 
Cat. No. SLP00, USA). Adiponectin levels were determined using 
a quantitative sandwich enzyme immunoassay technique 
(Quantikine® ELISA Human Total Adiponectin/Acrp30 
Immunoassay, R&D Systems, Inc., Cat. No. SRP300, USA). 
Adiponectin and leptin analyses were performed by the Centre 
of Excellence in Nutrition, Faculty of Health Sciences, University 
of North West, Potchefstroom, South Africa.
Blood specimens for the measurement of fasting venous plasma 
glucose (FVPG) were drawn into fluoride tubes. Analyses were 
performed by an accredited private laboratory in Bloemfontein, 
South Africa. Samples were centrifuged within four hours and 
FVPG was measured immediately after centrifuge using the 
glucose oxidase method, on a Beckman LX20® auto-analyser 
(Beckman Coulter, USA). Fasting serum triglyceride levels (normal 
value: fasting  <  150  mg/dL [1.70  mmol/L]), total cholesterol 
(normal value: fasting  <  200  mg/dL [5.18  mmol/L)] and high 
density lipoprotein (HDL) (normal levels for women: > 40 mg/dL 
[1.04 mmol/L]) were measured using enzymatic assay kits on a 
Beckman LX20® auto-analyser (Beckman Coulter, USA). Low 
density lipoprotein (LDL) cholesterol levels (normal 
value  <  100  mg/dL [2.59  mmol/L]) were calculated indirectly 
with the Friedewald equation,21 namely:
The International Diabetes Federation (IDF) and American 
Heart Association/National Heart, Lung and Blood Institute 
(AHA/NHLBI) criteria for the clinical diagnosis of the 
metabolic syndrome were applied in this study. Female 
participants were diagnosed with metabolic syndrome if 
they presented with at least three of the following five 
components, namely (i) waist circumference  ≥  80  cm; (ii) 
triglycerides ≥ 150 mg/dL; (iii) HDL-C < 50 mg/dL; (iv) blood 
pressure  ≥  130/85  mm Hg or history of treatment of 
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Statistical analysis
Data were analysed by the Department of Biostatistics, Faculty of 
Health Sciences, University of the Free State (UFS). Due to skew 
data distributions, medians and percentiles for the numerical 
variables were calculated. Significance of associations between 
categorical variables and numerical variables were determined 
using 95% confidence intervals (CI) for differences in percentages 
or medians. Correlations between continuous variables were 
determined using Spearman’s correlation coefficients.
Validity and reliability
To ensure validity, all methods (questionnaire, blood sampling 
and medical examination) aimed at achieving the objectives of 
the study as listed above. Participants were interviewed by 
trained final-year and postgraduate students from the 
Department of Nutrition and Dietetics at the UFS, supervised by 
lecturers, to complete standardised questionnaires related to 
household sociodemographic information and individual health 
information. Where necessary, Sesotho, Setswana and isiXhosa 
interpreters assisted the researchers. In order to address reliability 
of questionnaires, 10% of all interviews were repeated. Where 
the percentage of given responses to questions differed with 
more than 20%, the question was considered unreliable. No 
questions were found to be unreliable. All analyses on blood 
samples were done in accredited laboratories and the reliability 
of the blood sampling procedures was ensured by using standard 
laboratory techniques. Appropriate standardised measuring 
techniques were used to obtain reliable anthropometric 
measurements.
Ethical considerations
The study protocol was approved by the Ethics Committee of the 
Faculty of Health Sciences, UFS (ETOVS number 21/7), the 
Department of Health and local municipalities. All participants 
gave informed written consent.
Results
Adult participants included 22.1% male and 77.9% female 
participants, with a mean age of 42.5  years. Only 11 male 
participants had three or more components of metabolic 
syndrome, compared to 144 female participants. Due to the 
small number of suitable male participants, this article will only 
report on the results of urban African women identified with 
metabolic syndrome. Nine of the 144 female particiants were 
excluded due to their blood samples being inadequate to 
perform complete analyses. The mean age of the study group 
was 46.9 years.
Anthropometric and inflammatory parameters
Table 1 shows the association between BMI status and 
inflammatory parameters of urban African women identified 
with metabolic syndrome. Adiponectin levels in obese women 
(BMI ≥ 30 kg/m2) were significantly decreased compared to that 
of normal weight women (BMI 18.5–24.9 kg/m2) (95% CI −9.86; 
−2.94). Leptin levels in the obese group were significantly higher 
compared with the overweight (95% CI 14.91; 31.86) and normal 
weight group (95% CI 25.22; 45.63). A strong positive association 
was observed between L:A and BMI, with the obese group 
having significantly higher ratios than the normal weight group 
(95% CI 4.13; 8.52) and overweight group (95% CI 2.18; 6.20). The 
adiponectin levels of the overweight group were significantly 
lower than that of the normal weight group (95% CI −8.98; 
−0.91), whereas the leptin levels (95% CI 5.93; 18.37) and the L:A 
ratio (95% CI 0.81; 2.70) were significantly higher.
Components of metabolic syndrome, leptin and 
adiponectin
The association between the individual components of 
metabolic syndrome, leptin and adiponectin in urban African 
women are reflected in Table 2. Leptin levels were significantly 
higher (95% CI 9.27; 42.23) in women with increased waist 
circumference and there was a trend for adiponectin levels to be 
lower in these women (95% CI −6.63; 3.62). L:A was also 
significantly higher in women with increased waist circumference 
(95% CI 0.71; 8.01) and women with elevated fasting blood 
glucose (95% CI 0.36; 4.85), whereas L:A was significantly lower in 
women with elevated triglycerides (95% CI −3.27; −0.18). In 
women with elevated fasting blood glucose levels, adiponectin 
was significantly lower (95% CI −4.20; −0.88).
Six participants presented with all five components of metabolic 
syndrome. This group had a higher median age and a higher BMI 
(not significantly) than the participants identified with three or 
four components (Table 3). A trend towards an inverse association 
between adiponectin levels and the number of components was 
observed [three versus four components (95% CI −0.65; 2.72), 
three versus five components (95% CI −1.1; 6.54) and four versus 
five components (95% CI −2.28; 5.83)]. L:A ratio tended to be 
higher in the group identified with five components of metabolic 
syndrome [three versus five components (95% CI −14.22; 1.12) 
and four versus five components (95% CI −13.67; 1.73)].
As summarised in Table 4, leptin showed a strong positive 
correlation with BMI (r = 0.77) and waist circumference (r = 0.67). 
L:A ratio showed a strong positive correlations with both BMI 
(r = 0.67) and waist circumference (r = 0.55) and a weak positive 
correlation with fasting blood glucose (r  =  0.27). Adiponectin 
showed a weak negative correlations with BMI (r  =  −0.27) and 
fasting blood glucose (r = −0.28). No significant correlations were 
found between triglycerides, HDL-C and the inflammatory 
markers.
Table 1: Anthropometric and inflammatory parameters of urban African 
women identified with metabolic syndrome
*Only one woman had a BMI in the underweight category and was grouped with 
the normal weight participants.
#L:A ratio = leptin/adiponectin ratio.
Variable per body mass index 
(BMI) category
Median [Inter Quartile Range 
(IQR)]
Normal weight (BMI 18.5–24.9 kg/m2) (n = 17)*
 Age 50.0 [47.0–52.0]
 Adiponectin (μg/mL) 14.4 [9.3–19.1]
 Leptin (ng/mL) 9.1 [5.7–14.1]
 L:A ratio# 0.7 [0.5–1.3]
Overweight (BMI 25–29.9 kg/m2) (n = 35)
 Age 45.0 [37.0–54.0]
 Adiponectin (μg/mL) 9.2 [5.0–13.2]
 Leptin (ng/mL) 22.0 [12.3–31.7]
 L:A ratio 2.2 [1.4–5.4] 
Obese (BMI ≥ 30 kg/m2) (n = 83)
 Age 48.0 [41.0–56.0]
 Adiponectin (μg/mL) 6.4 [4.1–10.2]
 Leptin (ng/mL) 44.1 [31.8–75.7]
 L:A ratio 7.9 [3.6–11.9]
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Various studies have confirmed the involvement of leptin and 
adiponectin, both derived from adipose tissue, in the 
pathogenesis of obesity and metabolic syndrome.8,22 The results 
of the present study confirm previous observations illustrating 
an inverse relationship between adiponectin and leptin with 
altered adipocyte mass. 8,11,23 We also observed an increase in the 
calculated L:A ratio with increasing adiposity. Leptin and L:A 
were identified as markers that have strong positive correlations 
with both BMI and waist circumference.
It is well known that adiponectin has anti-inflammatory 
properties, cardio-protective characteristics (anti-atherogenic) 
and improves insulin sensitivity (anti-diabetic), while leptin has 
pro-inflammatory properties. Prior studies have demonstrated 
that adiponectin levels decrease across the glycaemic spectrum, 
while leptin levels increase. Schutte et al.11 found an inverse 
association between adiponectin and fasting blood glucose. We 
confirmed this inverse association between adiponectin and 
elevated fasting blood glucose levels, but could not illustrate a 
significant inverse association with elevated triglyceride levels as 
reported by Wolfson et al.14 Interestingly, we observed that L:A 
ratio had an inverse association with triglycerides and a direct 
association with fasting blood glucose levels.
Aging is an important biological factor for metabolic syndrome 
as it is associated with increased adiposity, mostly visceral 
obesity and altered adiponectin and leptin levels.22 The present 
study (age range 26–63  years) observed a trend between 
increasing age, BMI and the number of components identified 
for metabolic syndrome.
Previous studies have found that leptin, adiponectin, and the L:A 
ratio are informative biomarkers to evaluate the risk for metabolic 
syndrome.17,23–26 Yu et al.27 demonstrated that adiponectin levels 
decreased while leptin levels increased with an increased 
number of metabolic syndrome components in women. We 
observed that circulating adiponectin gradually decreased as 
the number of components for metabolic syndrome increased, 
although we could not illustrate an association between leptin 
Discussion
The prevalence of obesity is increasing worldwide and according 
to WHO reports, overweight and obesity are the fifth leading risk 
for global mortality.1 South African Demographic and Health 
Survey (SADHS) data indicate that older and urbanised African 
women in South Africa have significantly higher rates of 
obesity.3,5
Table 2: Association between the components of metabolic syndrome, leptin and adiponectin levels in urban African women
*Cut-off points for sub-Saharan Africans.
#HDL-C: high-density lipoprotein cholesterol.
Components of metabolic syndrome (cut-off 
points)
Median [Inter Quartile Range (IQR)]
Age (years) BMI (kg/m2) Leptin (ng/mL) Adiponectin (μg/mL) L:A ratio
Increased waist circumference*
≥ 80 cm (n = 129) 48.0 [40.0–56.0] 33.0 [27.7–39.2] 34.1 [20.7–51.1] 7.1 [4.7–12.2] 4.6 [2.0–9.4]
< 80 cm (n = 6) 48.5 [43.0–50.0] 21.2 [17.6–22.5] 4.9 [2.0–14.1] 10.0 [4.6–14.7] 0.9 [0.2–1.4]
Elevated triglycerides
≥ 150 mg/dl (1.7 mmol/L) (n = 45) 50.0 [45.0–55.0 ] 30.6 [24.8–38.0] 25.2 [14.1–45.0] 9.2 [5.8–14.4] 2.7 [1.3–7.5]
< 150 mg/dl (1.7 mmol/L) (n = 90) 46.5 [39.0–54.0] 33.1 [28.0–39.4] 37.1 [22.7–49.1] 6.9 [4.4–11.6] 5.7 [2.3–9.5]
Reduced HDL-C#
< 50 mg/dl (1.3 mmol/L) (n = 120) 47.0 [40.0–54.0] 32.6 [27.5–38.5] 32.5 [14.9–47.2] 7.2 [4.5–12.1] 4.4[1.9–8.7]
≥ 50 mg/dl (1.3 mmol/L) (n = 15) 51.0 [47.0–56.0] 33.0 [27.4–42.2] 40.6 [31.5–75.7] 7.2 [5.0–16.6] 4.0 [2.3–10.9]
Elevated fasting glucose
≥ 100 mg/dl (≥ 5.6 mmol/L) (n = 35) 51.0 [44.0–57.0] 33.1 [29.5–38.3] 36.9 [23.6–46.8] 4.9 [3.7–10.6] 7.0 [2.2–12.3]
< 100 mg/dl (≥ 5.6 mmol/L) (n = 100) 47.0 [39.5–53.5] 31.4 [27.0–39.3] 32.2[15.7–52.9] 8.8 [ 5.2–12.8] 3.8 [1.7–8.1]
Treatment of previously diagnosed hypertension
No (n = 7) 45.0 [41.0–51.0] 27.3 [24.8–40.2] 20.7 [12.2–51.1] 6.8 [4.9–19.1] 4.2 [0.7–5.2]
Yes (n = 128) 48.0 [40.0–55.5] 32.9 [27.7–38.7] 33.6 [18.9–48.4] 7.3 [4.6–12.1] 4.4 [1.9–9.4]
Table 3: Adiponectin and leptin values, and L:A ratio in urban African 
women identified with metabolic syndrome, according to number of 
metabolic syndrome components present
Variable Number of components Median [Inter Quartile 
Range (IQR)]
Three (n = 89) Four (n = 40) Five (n = 6)
Age (years) 47.0 [40.0–53.0] 50.0 [42.5–57.0] 53.5 [53.0–65.0]
BMI (kg/m2) 31.1 [27.2–39.7] 32.9 [28.4–37.7] 36.6 [35.2–38.0]
Adiponectin  
(μg/mL) 7.6 [5.0–12.4] 6.4 [4.1–10.8] 4.8 [3.7–10.6]
Leptin (ng/mL) 36.2 [17.7–54.7] 26.3 [14.5–44.9] 37.0 [25.8–98.1]
L:A ratio 4.4 [1.9–8.6] 3.5 [1.5–9.5] 9.6 [3.1–21.8]
Table 4: Spearman correlation coefficients between adiponectin, leptin 




Leptin (ng/mL) L:A ratio
Age (years) 0.16 −0.01 −0.01
BMI (kg/m2) −0.27 0.77 0.67
Waist circumference −0.16 0.67 0.55
Triglycerides 0.07 −0.15 −0.14
HDL-C 0.14 0.10 0.01
Fasting glucose −0.28 0.16 0.27
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concentrations and the increasing number of components. This 
may depend on the nature of the components. For example, 
waist circumference may not have the same impact as a history 
of previously diagnosed hypertension. Kotani and Sakane17 
demonstrated a significant and gradual increase in the L:A ratio 
corresponding to the number of components of metabolic 
syndrome. We also observed a significant increase in the L:A ratio 
in the group of women who presented with five components of 
metabolic syndrome. However, the small number of women in 
this group, precludes firm conclusions.
The present study also aimed to investigate which components 
of metabolic syndrome were more closely related to altered 
adiponectin and leptin levels in urban African women with 
metabolic syndrome. We found that fasting leptin and 
adiponectin levels and L:A ratio were associated with various 
components of metabolic syndrome.
This is one of the first studies investigating the relationship 
between obesity, pro-inflammatory and anti-inflammatory 
markers as well as the components of metabolic syndrome in 
urban African women with metabolic syndrome. Apart from the 
fact that our main study highlighted the need for serious 
recognition of the increasing burden of obesity and metabolic 
syndrome in urban African communities in South Africa,28 our 
findings also indicate that leptin, adiponectin and L:A ratio are 
significantly related to indices of adiposity. Elevated leptin, 
decreased adiponectin and an increased L:A ratio should be 
considered as warning signs, particularly in the obese individual, 
as these are associated with components of metabolic 
syndrome.
Limitations
The authors acknowledge the following limitations of the study. 
Only 11 male participants in the AHA-FS urban leg were identified 
with three or more risk factors for metabolic syndrome. Therefore, 
this article only reports on the results of urban African women 
identified with metabolic syndrome. We also acknowledge that 
due to the much younger mean age of the subject group 
identified with no components of metabolic syndrome, no 
suitable age-matched control group was available in the data-
set.
Conclusion and Recommendations
This study emphasises the associations between obesity, 
inflammatory biomarkers (adiponectin, leptin and L:A ratio) and 
components of metabolic syndrome. Based on the findings of 
this study, we recommend follow-up research to consider the 
following:
•  to evaluate the predictive value of these biomarkers to detect 
multiple risk factors in urban African women; and
•  to indicate which combinations of the metabolic syndrome cri-
teria best predict cardiovascular risk in these communities.
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